In this meta-analysis, the ORR after anti-PD-1/PD-L1 therapy was low, which may be not only related to PD-1/PD-L1 expression, but also related to the proportion of immune cell infiltration in gliomas, radiotherapy, and other factors. This evidence concerns the gene CD274 and central nervous system cancer.